GLEN ROCK, NJ: CEO to review: dronabinol, a Phase 3-ready medicine for the treatment of obstructive sleep apnea; and ampakines, Phase 2 drug candidates for multiple disrupted respiratory indications
...
Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.